Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 971 | 680 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 638 | 419 |
|
Invitae Brain Malformations Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 247 | 161 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Strabismus Syndrome or Congenital Fibrosis of Extraocular Muscles (Ocular Motility Disorder) Panel PreventionGenetics, part of Exact Sciences United States | 14 | 14 |
|
Congenital Fibrosis of Extraocular Muscles (Ocular Motility Disorder) Type 3A via the TUBB3 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Polymicrogyria panel. 17-gene NGS panel. Genologica Medica Spain | 22 | 17 |
|
Neuro-ophthalmology panel. NGS panel of 38 genes. Genologica Medica Spain | 75 | 38 |
|
Neuronal migration disorder panel. NGS panel of 58 genes. Genologica Medica Spain | 110 | 57 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
Congenital Fibrosis of Extraocular Muscles Asper Biogene Asper Biogene LLC Estonia | 4 | 4 |
|
Brain Malformations Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 111 | 56 |
|
Fibrosis of extraocular muscles, congenital: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 5 | 4 |
|
Neuro-Ophthalmic Disorders NGS Panel Fulgent Genetics United States | 52 | 26 |
|
Neuronal Migration Disorders NGS Panel Fulgent Genetics United States | 392 | 83 |
|
Cerebral Cortical Malformation NGS Panel Fulgent Genetics United States | 210 | 42 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.